Somatostatinoma (Q87577): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Tumor neuroendócrino raro, geralmente maligno, originado de células delta. Essa neoplasia produz grandes quantidades de somatostatina, que pode resultar em uma síndrome caracterizada por diarreia, esteatorreia, perda de peso e hipossecreção gástrica. Sessenta por cento são encontrados no pâncreas e 40% no duodeno ou jejuno. O pico de incidência ocorre entre 40 e 60 anos de idade; as mulheres são afetadas mais do que os homens em 2:1. | |||
| description / en | description / en | ||
A rare, usually malignant neuroendocrine tumour arizing from delta cells. This neoplasm produces large amounts of somatostatin, which may result in a syndrome characterised by diarrhea, steatorrhea, weight loss, and gastric hyposecretion. Sixty percent are found in the pancreas and 40% in the duodenum or jejunum. The peak incidence occurs between 40 and 60 years of age; women are affected more than men by 2:1. | |||
Revision as of 13:15, 15 August 2026
A rare, usually malignant neuroendocrine tumour arizing from delta cells. This neoplasm produces large amounts of somatostatin, which may result in a syndrome characterised by diarrhea, steatorrhea, weight loss, and gastric hyposecretion. Sixty percent are found in the pancreas and 40% in the duodenum or jejunum. The peak incidence occurs between 40 and 60 years of age; women are affected more than men by 2:1.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_219879696 |
||
| English | Somatostatinoma |
A rare, usually malignant neuroendocrine tumour arizing from delta cells. This neoplasm produces large amounts of somatostatin, which may result in a syndrome characterised by diarrhea, steatorrhea, weight loss, and gastric hyposecretion. Sixty percent are found in the pancreas and 40% in the duodenum or jejunum. The peak incidence occurs between 40 and 60 years of age; women are affected more than men by 2:1. |
